Search research articles
Contact Us
Filters
Showing results (301-310 of 322) with videos related to
Page
of 33
Sort By:
BJU International
|
December 12, 2024
The impact of post-nephroureterectomy surgically induced chronic kidney disease on survival outcomes
Dhruv Puri, Margaret F Meagher, Zhenjie Wu, et al.
Clinical Genitourinary Cancer
|
June 10, 2023
Impact of Variant Histology on Oncological Outcomes in Upper Tract Urothelial Carcinoma: Results From the ROBUUST Collaborative Group
Antoin Douglawi, Alireza Ghoreifi, Umberto Carbonara, et al.
European Urology Focus
|
February 7, 2021
A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)
Zhenjie Wu, Qi Chen, Hooman Djaladat, et al.
World Journal of Urology
|
October 12, 2024
Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry
Gabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
Minerva Urology and Nephrology
|
June 26, 2024
Robotic distal ureterectomy for high-risk distal ureteral urothelial carcinoma: a retrospective multicenter comparative analysis (ROBUUST 2.0 collaborative group)
Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
World Journal of Urology
|
November 18, 2024
Correction: Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry
Gabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
Journal of Endourology
|
January 12, 2022
Robotic <i>vs</i> Laparoscopic Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Propensity-Score Matched Pair "tetrafecta" Analysis (ROBUUST Collaborative Group)
Alessandro Veccia, Umberto Carbonara, Hooman Djaladat, et al.
Urologic Oncology
|
May 17, 2024
Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)
Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
World Journal of Urology
|
November 26, 2025
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma in the setting of clinical node positive disease: analysis of the ROBUUST registry
Margaret F Meagher, Zhenjie Wu, Antonio Franco, et al.
BJU International
|
September 12, 2024
Robot-assisted nephroureterectomy: surgical and mid-term oncological outcomes in over 1100 patients (ROBUUST 2.0 collaborative group)
Francesco Ditonno, Antonio Franco, Zhenjie Wu, et al.
Page
of 33
Search research articles
Search
Showing results (301-310 of 322) with videos related to
Sort By:
Page
of 33
BJU International
|
December 12, 2024
The impact of post-nephroureterectomy surgically induced chronic kidney disease on survival outcomes
Dhruv Puri, Margaret F Meagher, Zhenjie Wu, et al.
Clinical Genitourinary Cancer
|
June 10, 2023
Impact of Variant Histology on Oncological Outcomes in Upper Tract Urothelial Carcinoma: Results From the ROBUUST Collaborative Group
Antoin Douglawi, Alireza Ghoreifi, Umberto Carbonara, et al.
European Urology Focus
|
February 7, 2021
A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)
Zhenjie Wu, Qi Chen, Hooman Djaladat, et al.
World Journal of Urology
|
October 12, 2024
Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry
Gabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
Minerva Urology and Nephrology
|
June 26, 2024
Robotic distal ureterectomy for high-risk distal ureteral urothelial carcinoma: a retrospective multicenter comparative analysis (ROBUUST 2.0 collaborative group)
Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
World Journal of Urology
|
November 18, 2024
Correction: Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry
Gabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
Journal of Endourology
|
January 12, 2022
Robotic <i>vs</i> Laparoscopic Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Propensity-Score Matched Pair "tetrafecta" Analysis (ROBUUST Collaborative Group)
Alessandro Veccia, Umberto Carbonara, Hooman Djaladat, et al.
Urologic Oncology
|
May 17, 2024
Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)
Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
World Journal of Urology
|
November 26, 2025
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma in the setting of clinical node positive disease: analysis of the ROBUUST registry
Margaret F Meagher, Zhenjie Wu, Antonio Franco, et al.
BJU International
|
September 12, 2024
Robot-assisted nephroureterectomy: surgical and mid-term oncological outcomes in over 1100 patients (ROBUUST 2.0 collaborative group)
Francesco Ditonno, Antonio Franco, Zhenjie Wu, et al.
Page
of 33